Henrik Schinke
Penzberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer's disease assessment: findings from the Apollo study.
Journal: Clinical chemistry and laboratory medicine
Published: December 19, 2024
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Journal: Molecular cancer
Published: April 19, 2022
SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
Journal: Molecular oncology
Published: May 28, 2021
Interactome analysis reveals endocytosis and membrane recycling of EpCAM during differentiation of embryonic stem cells and carcinoma cells.
Journal: iScience
Published: April 15, 2021
Classification of endonasal HHT lesions using digital microscopy.
Journal: Orphanet journal of rare diseases
Published: December 04, 2020
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Journal: Cancer metastasis reviews
Published: June 09, 2020
Molecular Characterization of Lipoaspirates Used in Regenerative Head and Neck Surgery.
Journal: JAMA facial plastic surgery
Published: September 27, 2019
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
Journal: PLoS biology
Published: May 09, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026